AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

Related posts:

Moderna CEO Responds to RFK Jr.’s Crusade Against the Covid-19 Vaccine Check Out Highlights From WIRED’s 2025 Big Interview Event This AI Model Can Intuit How the Physical World Works Interstellar Comet 3I/Atlas Has Another Surprise: It’s Full of Alcohol